Skip to content

Sex Differences in the effecTs of brEaking uP Sedentary Behavior on vascUlar Function in Type 2 Diabetes

Sex Differences in the effecTs of brEaking uP Sedentary Behavior on vascUlar Function in Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05838586
Enrollment
34
Registered
2023-05-01
Start date
2023-07-31
Completion date
2025-08-18
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Type 2 Diabetes

Brief summary

Type 2 diabetes (T2D) confers a high risk of cardiovascular disease (CVD), particularly among older adults who tend to be physically inactive. Prolonged sedentary behavior (SB) has been shown to negatively influence markers of cardiovascular risk (e.g., blood glucose, blood pressure), even among individuals who are physically active. Most studies that have examined the effects of breaking up SB have focused on young healthy males and prioritized glycemic outcomes. Additionally, sex differences in these outcomes have not been adequately examined. The present study will address these gaps. This 3-arm crossover randomized controlled trial will compare the effects of 3 SB conditions on markers of vascular function. The 3 conditions are: 1) 4 hours of prolonged SB, 2) 4 hours of SB broken up by 5 minutes of self-paced walking every hour, and 3) 4 hours of SB with one 20-minute bout of self-paced walking. In addition to examining the overall effects of each condition, sex differences in physiological responses will be evaluated.

Interventions

BEHAVIORALprolonged SB

4 hours of prolonged SB

BEHAVIORALSB broken 1

4 hours of SB broken up by 5 minutes of self-paced walking every hour

BEHAVIORALSB broken 2

4 hours of SB with one 20-minute bout of self-paced walking

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Participants will complete three interventions in a randomized order, separated by \>=6 and \<90 days. The interventions are: 1. 4 hours of prolonged SB (control, CON) 2. 4 hours of SB broken up by 5 minutes of self-paced walking every hour (BREAK) 3. 4 hours of SB with one 20-minute bout of self-paced walking (BOUT)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥60 years * Postmenopausal (females only, ≥12 months without a menstrual period) * Type 2 diabetes (hemoglobin A1c ≥6.5% and/or previous diagnosis of type 2 diabetes) * ≥6 hours/day sedentary (assessed via IPAQ) * Willingness to abstain from food, caffeine, alcohol and exercise for \>= 24 hours, and tobacco/smoking for ≥12 hours prior to each intervention visit * Ability to speak and read English

Exclusion criteria

* Type 1 diabetes * Uncontrolled hypertension (resting systolic ≥160 or diastolic ≥110 mmHg) * Initiation of hormone therapy or change in hormone therapy dose/frequency/route of administration in the previous 3 months * Renal dialysis * History of deep vein thrombosis (DVT) * Evidence of cognitive impairment that could impact ability to consent and/or participation (Mini-Cog score \<3) * Achieving physical activity guidelines (≥150 minutes of MVPA/week, assessed via IPAQ)) * Physical impairment or disability that interferes with ability to engage in PA (e.g., severe osteoarthritis, lower extremity amputation \[other than toe(s)/partial foot\], use of a walker or wheelchair, etc.), * Unstable medical/psychiatric condition that could impact study participation

Design outcomes

Primary

MeasureTime frameDescription
iAUC of SBP90 daysNet incremental area under the curve (iAUC) of systolic blood pressure (SBP)

Secondary

MeasureTime frameDescription
Net iAUC of DBP90 daysNet iAUC of diastolic blood pressure
Net iAUC of of MAP90 daysNet iAUC of mean arterial pressure
Net iAUC of HR90 daysNet iAUC of heart rate

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026